Chemcon Speciality Chemicals Limited has confirmed that its promoters have not created any fresh encumbrances on their shareholdings during the financial year ending March 31, 2026. The disclosure ensures that the shareholding structure remains free of undisclosed charges, providing clarity to investors regarding the promoters' stake. The declarations were submitted to BSE Limited and National Stock Exchange of India Limited on April 7, 2026.

The filings were made pursuant to Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to declare whether they, along with persons acting in concert, have encumbered shares directly or indirectly. The submission confirms compliance with this regulatory requirement for the specified period.

Promoter Declarations

The company enclosed specific declarations from its key promoters affirming the absence of new encumbrances. The following table details the promoters who submitted the confirmations:

Each promoter explicitly stated that they had not made any encumbrance on the shares of Chemcon Speciality Chemicals Limited other than those already disclosed to the stock exchanges during FY26. The declarations were addressed to the Audit Committee of the company as well as the stock exchanges.

Shahilkumar Kapatel, Company Secretary & Compliance Officer of Chemcon Speciality Chemicals Limited, signed the submission to the exchanges on April 7, 2026. The filing serves as a formal record of the promoters' compliance with takeover regulations regarding the pledging or charging of shares.

Chemcon Speciality Chemicals has announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a net profit of ₹6.4 crore for the quarter ended March 31, 2026, compared to ₹3.9 crore in the corresponding period of the previous year. For the full financial year 2025-26, the net profit stood at ₹23.6 crore, while revenue from operations reached ₹240 crore. The results were published in newspapers on May 22, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

Revenue from operations for the year ended March 31, 2026, increased to ₹240 crore from ₹207.4 crore in the previous year. Total income for the year rose to ₹255.4 crore. The company's basic earnings per share (EPS) for the year was recorded at ₹6.44. On a quarterly basis, Q4 revenue came in at ₹75.4 crore compared to ₹54.9 crore in the same period of the previous year, reflecting strong year-on-year growth.

The following table summarises the key financial metrics for the quarter and full year:

EBITDA Performance

Chemcon Speciality Chemicals also reported improved operational profitability for the quarter. Q4 EBITDA stood at ₹8.9 crore compared to ₹5.8 crore in the corresponding period of the previous year. The EBITDA margin expanded to 11.8% from 10.5% year-on-year, indicating improved cost efficiency and operating leverage during the quarter.

Strategic Developments

During the quarter, both the Organic and Inorganic Chemicals segments delivered improved performance, driven by higher volumes and better realizations across key products. Newer products such as Bromobenzene and 2-Bromo have seen encouraging response from end user industries like pharmaceutical, agrochemical, aromatic chemical, and other end-user industries. On the strategic front, the acquisition of Shivam Petrochem Industries through a slump sale is progressing well, with integration activities and license transfers nearing completion. The acquired business is expected to begin contributing to revenues in the coming quarters and will further strengthen the company's presence across bulk drugs, chemical intermediates, solvents, and specialty chemicals.

Auditor and Board Appointments

M/s Shah Mehta & Bakshi, Chartered Accountants, audited the financial results and issued an audit report with an unmodified opinion. Additionally, the board approved the re-appointment of M/s Chetan Gandhi & Associates as Cost Auditors and M/s Kulin Shah & Associates as Internal Auditors for the financial year 2026-27.